Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer.
HPV genotype
head and neck cancer
human papillomavirus
oropharyngeal cancer
oropharyngeal squamous cell carcinoma
Journal
International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
revised:
10
11
2021
received:
28
05
2021
accepted:
25
11
2021
pubmed:
12
12
2021
medline:
15
2
2022
entrez:
11
12
2021
Statut:
ppublish
Résumé
The increases observed in incidence and survival of oropharyngeal squamous cell carcinoma (OPSCC) have been attributed to human papillomavirus (HPV) infection, but the survival-impact of specific genotypes is poorly understood. We investigated the potential influence of HPV genotypes on survival in HPV-positive (HPV+) OPSCC. All patients with HPV+/p16+ OPSCC and available genotype data within the period 2011 to 2017 in Eastern Denmark were included. Descriptive statistics on clinical and tumor data, as well as overall survival (OS) and recurrence-free survival (RFS) with Cox hazard models and Kaplan-Meier plots were performed. Overall, 769 HPV+/p16+ OPSCC patients were included of which genotype HPV16 accounted for 86% (n = 662). Compared to high-risk non-HPV16 genotypes (HR non-HPV16), HPV16 patients were younger at diagnosis (median years, 60 vs 64), had a higher male to female ratio (3.7:1 vs 2.1:1), and lower performance scores of ≤1 (90%, n = 559, vs 81%, n = 74). Regarding 5-year OS and RFS, no difference was observed between HPV16 and HR non-HPV16 patients. Subgrouping the HR non-HPV16 group into HPV33 (n = 57), HPV35 (n = 26) and "other genotypes" (n = 24) a significantly worse OS in the "other genotypes" group (hazard rate: 2.33, P = .027) was shown. With similar survival results between HPV16 and non-HPV16 genotypes, genotyping in OPSCC is interesting from an epidemiological point of view as well as in vaccination programs, but not a necessary addition in prognostication of HPV+/p16+ OPSCC.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1174-1183Informations de copyright
© 2021 UICC.
Références
Bouvard V, Baan R, Straif K, et al. A review of human carcinogens-part B: biological agents. Lancet Oncol. 2009;10:321-322.
Taberna M, Mena M, Pavón MA, Alemany L, Gillison ML, Mesía R. Human papillomavirus-related oropharyngeal cancer. Ann Oncol. 2017;28:2386-2398.
Haeggblom L, Attoff T, Jingru Y, et al. Changes in incidence and prevalence of human papillomavirus in tonsillar and base of tongue cancer during 2000-2016 in the Stockholm region and Sweden. Head Neck. 2018;41:1-8.
Zamani M, Grønhøj C, Jensen DH, et al. The current epidemic of HPV-associated oropharyngeal cancer: an 18-year Danish population-based study with 2,169 patients. Eur J Cancer. 2020;134:52-59.
Stjernstrøm KD, Jensen JS, Jakobsen KK, Grønhøj C, von Buchwald C. Current status of human papillomavirus positivity in oropharyngeal squamous cell carcinoma in Europe: a systematic review. Viruses. 2019;139:1112-1116.
Carlander A-LF, Grønhøj Larsen C, Jensen DH, et al. Continuing rise in oropharyngeal cancer in a high HPV prevalence area: a Danish population-based study from 2011 to 2014. Eur J Cancer. 2017;70:75-82.
Dalianis T. Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (review). Int J Oncol. 2014;45:1799-1805.
World Health Organization. Human papillomaviruses. Geneva: WHO; 2006:689.
Hammer A, Rositch A, Qeadan F, Gravitt PE, Blaakaer J. Age-specific prevalence of HPV16/18 genotypes in cervical cancer: a systematic review and meta-analysis. Int J Cancer. 2016;138:2795-2803.
Snijders PJ, van den Brule AJ, Schrijnemakers HF, Raaphorst PM, Meijer CJ, Walboomers JM. Human papillomavirus type 33 in a tonsillar carcinoma generates its putative E7 mRNA via two E6* transcript species which are terminated at different early region poly(A) sites. J Virol. 1992;66:3172-3178.
Snijders PJ, Meijer CJ, van den Brule AJ, Schrijnemakers HF, Snow GB, Walboomers JM. Human papillomavirus (HPV) type 16 and 33 E6/E7 region transcripts in tonsillar carcinomas can originate from integrated and episomal HPV DNA. J Gen Virol. 1992;73(Pt 8):2059-2066.
Fossum GH, Lie AK, Jebsen P, Sandlie LE, Mork J. Human papillomavirus in oropharyngeal squamous cell carcinoma in south-eastern Norway: prevalence, genotype, and survival. Eur Arch Otorhinolaryngol. 2017;274:4003-4010.
Goodman MT, Saraiya M, Thompson TD, et al. Human papillomavirus genotype and oropharynx cancer survival in the United States of America. Eur J Cancer. 2015;51:2759-2767.
Varier I, Keeley BR, Krupar R, et al. Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes. Head Neck. 2016;38:1330-1337.
Mazul AL, Rodriguez-Ormaza N, Taylor JM, et al. Prognostic significance of non-HPV16 genotypes in oropharyngeal squamous cell carcinoma. Oral Oncol. 2016;61:98-103.
Chatfield-Reed K, Gui S, O'Neill WQ, Teknos TN, Pan Q. HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes. Oral Oncol. 2020;100:104488.
Garnaes E, Kiss K, Andersen L, et al. A high and increasing HPV prevalence in tonsillar cancers in eastern Denmark, 2000-2010: the largest registry-based study to date. Int J Cancer. 2015;136:2196-2203.
Bjerregaard B, Larsen OB. The Danish pathology register. Scand J Public Health. 2011;39:72-74.
Overgaard J, Jovanovic A, Godballe C, Grau EJ. The Danish head and neck cancer database. Clin Epidemiol. 2016;8:491-496.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377-381.
Grønhøj C, Jensen DH, Dehlendorff C, et al. Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European multicentre study (OroGrams). Br J Cancer. 2018;118:1672-1681.
Grønhøj Larsen C, Gyldenløve M, Jensen DH, et al. Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review. Br J Cancer. 2014;110:1587-1594.
Schmitt M, Dondog B, Waterboer T, Pawlita M. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol. 2008;46:1050-1059.
Van Doorslaer K, Tan Q, Xirasagar S, et al. The papillomavirus episteme: a central resource for papillomavirus sequence data and analysis. Nucleic Acids Res. 2013;41:D571-D578.
R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2020.
Nichols AC, Dhaliwal SS, Palma DA, et al. Does HPV type affect outcome in oropharyngeal cancer? J Otolaryngol Head Neck Surg. 2013;42:9.
No JH, Sung MW, Hah JH, et al. Prevalence and prognostic value of human papillomavirus genotypes in tonsillar squamous cell carcinoma: a Korean multicenter study. Cancer. 2015;121:535-544.
Goodman MT, Shvetsov YB, McDuffie K, et al. Sequential acquisition of human papillomavirus infection of the anus and cervix: the Hawaii HPV Cohort Study. J Infect Dis. 2010;201:1331.
WHO. Human papillomavirus (HPV) and cervical cancer. Geneva: World Health Organisation; 2020.
Christensen JT, Grønhøj C, Zamani M, et al. Association between oropharyngeal cancers with known HPV and p16 status and cervical intraepithelial neoplasia: a Danish population-based study. Acta Oncol (Stockholm, Sweden). 2019;58:267-272.
Rasmussen JH, Grønhøj C, Håkansson K, Friborg J, Andersen E, Lelkaitis G. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma. Ann Oncol. 2019;30:629-636.
Rietbergen MM, Snijders PJF, Beekzada D, et al. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas. Int J Cancer. 2014;134:2366-2372.
Slebos RJC, Yi Y, Ely K, et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res. 2006;12:701-709.
Howard JD, Chung CH. Biology of human papillomavirus-related oropharyngeal cancer. Semin Radiat Oncol. 2012;22:187-193.
Carlander AF, Jakobsen KK, Bendtsen SK, et al. A contemporary systematic review on repartition of HPV-positivity in oropharyngeal cancer worldwide. Viruses. 2021;13:1326.